Profits improve at biotech firm

Dublin based pharmaceuticals group Trinity Biotech has reported a marginal increase in pre-tax profits to $1

Dublin based pharmaceuticals group Trinity Biotech has reported a marginal increase in pre-tax profits to $1.45 million for the first quarter of 2000. Sales in the quarter were 21 per cent higher on $8.3 million. The small increase in profits is attributed to higher expenses as a result of recent acquisitions as well as increased investment in sales and marketing.

  • —

    From maternity leave to remote working: Submit your work-related questions here

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox